Silo Pharma, Inc.
Small-molecule therapeutic candidates for psychiatric and CNS disorders, including SPC-15 for PTSD, SP-26 for fibromyalgia, and preclinical assets for Alzheimer's and multiple sclerosis
- Sector
- Biotech
- Headquarters
- SARASOTA, FL
- Founded
- 2010
- Latest Form D
- $2.3M, Aug 2024
- Total capital
- $11.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $11.6M
- 9 Form D · last Aug 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 17 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 9th filing$2.3M
- Private capital raisedForm D · SEC · 8th filing$2.1M
- Private capital raisedForm D · SEC · 7th filing$4.3M
- Private capital raisedForm D · SEC · 6th filing$2.4M
- Private capital raisedForm D · SEC · 5th filing$115K
- Private capital raisedForm D · SEC · 4th filing$25K
- Private capital raisedForm D · SEC · 3rd filing$435K
- Offering registeredForm D · SEC · 2nd filing$2M
- Private capital raisedForm D · SEC · 1st filing$7K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Daniel RyweckExecutive OfficerNamed in SEC Form D filings
- Eric WeisblumExecutive Officer, DirectorNamed in SEC Form D filings
- Jeff PavellDirectorNamed in SEC Form D filings
- Kevin MunozDirectorNamed in SEC Form D filings
- Wayne LinsleyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 17- PendingMethods And Compositions For Pain ManagementUSPTOApplication 19076967
- PendingUse Of Cns-homing Targeting Peptides For Treating Neurological DisordersUSPTOApplication 18423557
- PendingUse Of Psilocybin In Cancer TreatmentUSPTOApplication 18257014
Show all 17 patent records
- Methods And Compositions For Pain ManagementSep 18, 2025 · Application 19076967Pending
- Use Of Cns-homing Targeting Peptides For Treating Neurological DisordersAug 1, 2024 · Application 18423557Pending
- Use Of Psilocybin In Cancer TreatmentFeb 22, 2024 · Application 18257014Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory Drugs And PsilocybinNov 2, 2023 · Application 18004546Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory DrugsAug 10, 2023 · Application 18004633Pending
- Central Nervous System Delivery Of PsilocybinAug 3, 2023 · Application 18004400Pending
- Use Of Cns-homing Targeting Peptides For Treating Neurological DisordersApplication 63482192Pending
- Methods And Compositions For Pain ManagementApplication 63564833Pending
- Chronic, combinatorial targeting of NMDARs and 5-HT4Rs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagiaApplication 63744572Pending
- Use Of Psilocybin In Cancer TreatmentApplication PCTUS2021062888Pending
- Central Nervous System Delivery Of PsilocybinApplication PCTUS2021044031Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory Drugs And PsilocybinApplication PCTUS2021044032Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory DrugsApplication PCTUS2021044034Pending
- Use Of Psilocybin In Cancer TreatmentApplication 63124827Pending
- Central Nervous System Delivery Of PsilocybinApplication 63060573Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory Drugs And PsilocybinApplication 63060577Pending
- Central Nervous System Delivery Of Nonsteroidal Anti-inflammatory DrugsApplication 63060569Pending
Related companies, and why
- Encellin, Inc.Similar federal contract value in Biotech · null in contracts
- MACROGENICS INCSimilar federal contract value in Biotech · null in contracts
- Akebia Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- FENNEC PHARMACEUTICALS INC.Similar federal contract value in Biotech · null in contracts
- Syrna Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Vitra Labs, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .